FWM
MRK icon

Focused Wealth Management’s Merck MRK Stock Holding History

Focused Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$866K Buy
7,200
+203
+3% +$23.4K 0.09% 82
2025
Q4 		$736K Sell
6,997
-412
-6% -$38.7K 0.08% 88
2025
Q3 		$622K Sell
7,409
-11
-0.1% -$906 0.07% 93
2025
Q2 		$587K Sell
7,420
-584
-7% -$46.4K 0.07% 90
2025
Q1 		$718K Buy
8,004
+484
+6% +$45.2K 0.1% 69
2024
Q4 		$748K Buy
7,520
+128
+2% +$13.2K 0.1% 66
2024
Q3 		$839K Buy
7,392
+26
+0.4% +$3.09K 0.11% 77
2024
Q2 		$912K Buy
7,366
+28
+0.4% +$3.61K 0.13% 67
2024
Q1 		$968K Buy
7,338
+199
+3% +$24.5K 0.15% 63
2023
Q4 		$778K Buy
7,139
+207
+3% +$21.5K 0.13% 65
2023
Q3 		$714K Buy
6,932
+16
+0.2% +$1.73K 0.13% 64
2023
Q2 		$798K Buy
6,916
+17
+0.2% +$1.93K 0.14% 63
2023
Q1 		$734K Buy
6,899
+16
+0.2% +$1.73K 0.15% 63
2022
Q4 		$764K Buy
6,883
+19
+0.3% +$1.94K 0.16% 64
2022
Q3 		$591K Buy
6,864
+18
+0.3% +$1.61K 0.12% 71
2022
Q2 		$624K Sell
6,846
-53
-0.8% -$4.7K 0.11% 80
2022
Q1 		$566K Buy
6,899
+22
+0.3% +$1.74K 0.09% 85
2021
Q4 		$527K Sell
6,877
-1,661
-19% -$132K 0.08% 91
2021
Q3 		$641K Buy
8,538
+33
+0.4% +$2.51K 0.1% 82
2021
Q2 		$661K Sell
8,505
-497
-6% -$37K 0.11% 81
2021
Q1 		$662K Buy
9,002
+302
+3% +$22.3K 0.12% 84
2020
Q4 		$679K Buy
8,700
+14
+0.2% +$1.07K 0.13% 79
2020
Q3 		$688K Buy
8,686
+1,324
+18% +$104K 0.15% 67
2020
Q2 		$543K Buy
7,362
+40
+0.5% +$3.01K 0.13% 74
2020
Q1 		$538K Sell
7,322
-3,088
-30% -$243K 0.16% 69
2019
Q4 		$903K Buy
10,410
+4
+0% +$329 0.21% 58
2019
Q3 		$836K Sell
10,406
-467
-4% -$37.4K 0.23% 61
2019
Q2 		$870K Buy
10,873
+574
+6% +$44K 0.23% 56
2019
Q1 		$817K Buy
10,299
+455
+5% +$34K 0.25% 61
2018
Q4 		$718K Buy
9,844
+4,092
+71% +$289K 0.25% 63
2018
Q3 		$389K Sell
5,752
-218
-4% -$13.9K 0.13% 95
2018
Q2 		$346K Sell
5,970
-1,283
-18% -$72.4K 0.12% 101
2018
Q1 		$377K Sell
7,253
-374
-5% -$20.2K 0.12% 101
2017
Q4 		$410K Sell
7,627
-4,464
-37% -$247K 0.13% 94
2017
Q3 		$739K Buy
12,091
+2,821
+30% +$171K 0.25% 63
2017
Q2 		$567K Buy
9,270
+13
+0.1% +$791 0.21% 71
2017
Q1 		$561K Sell
9,257
-778
-8% -$47.2K 0.22% 72
2016
Q4 		$564K Buy
10,035
+2,195
+28% +$128K 0.24% 68
2016
Q3 		$467K Buy
7,840
+15
+0.2% +$877 0.21% 77
2016
Q2 		$430K Sell
7,825
-551
-7% -$29.3K 0.2% 77
2016
Q1 		$423K Buy
8,376
+750
+10% +$36.7K 0.23% 74
2015
Q4 		$384K Buy
7,626
+446
+6% +$22.5K 0.22% 78
2015
Q3 		$338K Sell
7,180
-499
-6% -$26.5K 0.21% 71
2015
Q2 		$417K Sell
7,679
-3,728
-33% -$209K 0.26% 65
2015
Q1 		$626K Buy
11,407
+255
+2% +$14.4K 0.38% 50
2014
Q4 		$604K Buy
11,152
+2
+0% +$111 0.43% 44
2014
Q3 		$631K Sell
11,150
-8
-0.1% -$449 0.48% 51
2014
Q2 		$616K Sell
11,158
-153
-1% -$8.35K 0.48% 44
2014
Q1 		$613K Buy
11,311
+124
+1% +$6.42K 0.51% 45
2013
Q4 		$534K Sell
11,187
-57
-0.5% -$2.61K 0.45% 46
2013
Q3 		$511K Buy
+11,244
New +$513K 0.49% 45

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Focused Wealth Management's MRK Position: Q1 2026 in Review

Focused Wealth Management increased its Merck (MRK) stake by 2.9% in Q1 2026, buying an estimated $23.4K and bringing the position to 7,200 shares worth $866K. The position accounts for 0.09% of the portfolio, ranked #82.

Focused Wealth Management first reported a position in MRK in Q3 2013 and has held it in 51 quarters since. The position peaked at $968K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Focused Wealth Management held 7,200 shares of Merck worth $866K as of Q1 2026.
  • Focused Wealth Management bought 203 Merck shares in Q1 2026, an estimated $23.4K.
  • Merck made up 0.09% of Focused Wealth Management's portfolio in Q1 2026, its #82 holding.
  • Focused Wealth Management first reported a position in Merck in Q3 2013 and has held it in 51 quarters since.
  • Focused Wealth Management's Merck position peaked at $968K in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Focused Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.